Abiomed, Inc. (ABMD) Tops Q3 EPS by 12c; Boosts Lower-End of FY12 Revs Outlook
ABMD Hot Sheet
EPS Growth %: +1,200.0%Financial Fact:
Net loss: 2.92M
Today's EPS Names:
TARO, BRLI, TLB, More
Abiomed, Inc. (NASDAQ: ABMD) reported Q3 EPS of $0.11, $0.12 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $32.2 million versus the consensus estimate of $31.43 million.
Sees FY2012 revenue of $122-$125 million, versus prior guidance of $120-$125 million and the consensus of $123.3 million.
For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Sees FY2012 revenue of $122-$125 million, versus prior guidance of $120-$125 million and the consensus of $123.3 million.
For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Infoblox (BLOX) Tops Q3 EPS by 4c; Guides Q4
- Toro Co. (TTC) Tops Q1 EPS by 13c; Guides FY12 EPS Above Views; to Split Stock
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
